08/31/2023 Septerna Bolsters Leadership Team as the Company Advances its Multi-Product Pipeline Toward Clinical Studies Read More
07/11/2023 Septerna Secures $150 Million in Series B Financing to Advance Pipeline of Novel GPCR-targeted Medicines Read More
12/19/2022 Septerna Announces the Formation of a Cross-Functional Scientific and Drug Discovery Advisory Board Read More
07/28/2022 Septerna Strengthens Leadership Team to Advance Novel Small Molecule GPCR Medicines Read More
01/27/2022 Septerna Launches with $100 Million Series A Financing to Expand the Frontier of GPCR-targeted Medicines using the Native Complex™ Platform Read More